LPCN

LIPOCINE INC NEW

LPCN·53630X203·US·Common Stock·Healthcare - Biotechnology-13D/G

LPCN (LIPOCINE INC NEW) is held by 25 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($1.6M), BlackRock, Inc. ($713,283), GEODE CAPITAL MANAGEMENT, LLC ($504,741). Net institutional sentiment: Bullish.

25
Holders
Avg rating(5 Elite)
$5.1M
Total Value
68% (26)
Fund Consensus
17 buying - 8 selling
LPCNSmart Money Verdict
View all
Held by 25 funds
5 elite
Who's Trading
ActivistIKIkarian Capital, LLC6.3%May 15, 2026
ActivistSMSquadron Master Fund LP6.2%May 15, 2026
InsiderHWHiguchi John W.Buy $81KApr 7, 2026
InsiderHWHiguchi John W.Buy $252KApr 6, 2026
InsiderPVPatel Mahesh V.Buy $51KApr 6, 2026
InsiderPVPatel Mahesh V.Buy $51KApr 2, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
200,668$1.6M0.0%-71.38%
39
Unchanged
89,272$713,2830.0%-47.38%
0
Increased
63,135(+1.1%)$504,7410.0%-87.82%
17
Increased
38,497(+2.9%)$307,5910.0%-60.06%
24
New
33,750$269,6630.0%-71.38%
32
New
32,413$258,9800.0%-71.38%
32
New
29,088$232,4130.0%-71.38%
35
Decreased
24,908$199,0150.0%-34.73%
0
Increased
22,407(+20.3%)$179,0320.0%-35.56%
18
Increased
20,027(+89.4%)$160,0160.0%-67.62%
24
Increased
19,122(+57.5%)$152,7850.0%-65.17%
22
New
17,923$143,2050.0%-71.38%
31
Decreased
13,042(-0.9%)$104,2060.0%-70.75%
0
Decreased
11,448(-28.9%)$91,4690.0%-63.32%
0
New
9,412$75,2020.0%-71.38%
33
Decreased
3,494(-37.6%)$27,9170.0%-55.60%
0
New
2,706$21,6210.0%-71.38%
29
New
1,691$13,5110.0%-71.38%
27
Increased
626(+713.0%)$5,0050.0%-69.25%
17
Decreased
574(-23.6%)$4,5860.0%-69.29%
0

Showing 1-20 of 26

1 / 2

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used